Clinical Trial Results:
A Phase IV, Single-centre, Open-label Study to Evaluate the Immunogenicity and Safety of the 2009/2010 Formulation of the Enzira® Vaccine in Two Groups of Healthy Volunteers: ‘Adults’ (aged ≥ 18 to < 60 years) and ‘Older Adults’ (aged ≥ 60 years)
Summary
|
|
EudraCT number |
2009-011450-18 |
Trial protocol |
GB |
Global completion date |
28 May 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
24 Mar 2016
|
First version publication date |
24 Mar 2016
|
Other versions |
|
Summary report(s) |
CSL_CSLCT-NHF-09-57_Result_Summary-Final |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.